Continuous subcutaneous levodopa/carbidopa infusion (ND0612) for patients with Parkinson's disease and motor fluctuations: A Phase 3, active-controlled study (BouNDless).

Saved in:
Bibliographic Details
Title: Continuous subcutaneous levodopa/carbidopa infusion (ND0612) for patients with Parkinson's disease and motor fluctuations: A Phase 3, active-controlled study (BouNDless).
Authors: Stocchi, F.1 (AUTHOR), Espay, A.2 (AUTHOR), Albanese, A.3 (AUTHOR), Ellenbogen, A.4 (AUTHOR), Ferreira, J.J.5 (AUTHOR), Giladi, N.6 (AUTHOR), Gurevich, T.7 (AUTHOR), Hassin-Baer, S.8 (AUTHOR), Hernandez-Vara, J.9 (AUTHOR), Isaacson, S.10 (AUTHOR), Kieburtz, K.11 (AUTHOR), LeWitt, P.12 (AUTHOR), Lopez-Manzanares, L.13 (AUTHOR), Olanow, C.W.11 (AUTHOR), Pahwa, R.14 (AUTHOR), Poewe, W.15 (AUTHOR), Sarva, H.16 (AUTHOR), Yardeni, T.17 (AUTHOR), Adar, L.17 (AUTHOR), Lopes, N.17 (AUTHOR)
Source: Parkinsonism & Related Disorders. May2024, Vol. 122, pN.PAG-N.PAG. 1p.
Database: Academic Search Ultimate
Description
ISSN:13538020
DOI:10.1016/j.parkreldis.2024.106149